Financial reports
10-K
2023 FY
Annual report
29 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
4 Apr 22
NT 10-K
Notice of late annual filing
31 Mar 22
Current reports
8-K
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
28 Mar 24
8-K
CV Sciences, Inc. Acquires Cultured Foods To Enter Plant-Based Food Market
12 Dec 23
8-K
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
14 Nov 23
8-K
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
14 Aug 23
8-K
Departure of Directors or Certain Officers
5 Jun 23
8-K
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
15 May 23
8-K
CV Sciences, Inc. Reports Fiscal Year-End 2022 Financial Results
29 Mar 23
8-K
Regulation FD Disclosure
2 Mar 23
8-K
CV Sciences, Inc. Reports Third Quarter 2022 Financial Results
14 Nov 22
8-K
Departure of Directors or Certain Officers
25 Oct 22
Registration and prospectus
424B5
Prospectus supplement for primary offering
31 Mar 22
424B5
Prospectus supplement for primary offering
28 Mar 22
424B5
Prospectus supplement for primary offering
15 Nov 21
424B5
Prospectus supplement for primary offering
8 Dec 20
S-3
Shelf registration
21 Apr 20
D
$770K in debt, sold $750K, 1 investor
3 Apr 17
D
$2M in debt, sold $2M, 1 investor
8 Jun 16
RW
Registration withdrawal request
23 Mar 16
S-1/A
IPO registration (amended)
23 Sep 15
AW
Withdrawal of amendment
3 Aug 15
Proxies
DEF 14A
Definitive proxy
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 23
DEF 14A
Definitive proxy
15 Apr 22
PRE 14A
Preliminary proxy
4 Apr 22
DEF 14A
Definitive proxy
9 Apr 21
PRE 14A
Preliminary proxy
29 Mar 21
DEF 14A
Definitive proxy
26 Mar 21
DEFA14A
Additional proxy soliciting materials
2 Jun 20
DEF 14A
Definitive proxy
31 Mar 20
PRE 14A
Preliminary proxy
20 Mar 20
Other
EFFECT
Notice of effectiveness
1 May 20
CORRESP
Correspondence with SEC
28 Apr 20
UPLOAD
Letter from SEC
24 Apr 20
CT ORDER
Confidential treatment order
18 Aug 16
EFFECT
Notice of effectiveness
29 Jul 11
CORRESP
Correspondence with SEC
27 Jul 11
UPLOAD
Letter from SEC
22 Jul 11
UPLOAD
Letter from SEC
15 Jul 11
UPLOAD
Letter from SEC
6 Jul 11
UPLOAD
Letter from SEC
29 Apr 11
Ownership